| Magnetic core-shell nanoparticles for drug delivery by nebulization NK Verma, K Crosbie-Staunton, A Satti, S Gallagher, KB Ryan, T Doody, ... Journal of Nanobiotechnology 11, 1-12, 2013 | 209 | 2013 |
| 36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016 RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical care 20, 13-182, 2016 | 188 | 2016 |
| Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications P Galvin, D Thompson, KB Ryan, A McCarthy, AC Moore, CS Burke, ... Cellular and Molecular Life Sciences 69, 389-404, 2012 | 157 | 2012 |
| Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine JB Fink, S Ehrmann, J Li, P Dailey, P McKiernan, C Darquenne, AR Martin, ... Journal of aerosol medicine and pulmonary drug delivery 33 (6), 300-304, 2020 | 143 | 2020 |
| Nasal high flow nebulization in infants and toddlers: an in vitro and in vivo scintigraphic study F Réminiac, L Vecellio, RM Loughlin, D Le Pennec, M Cabrera, ... Pediatric pulmonology 52 (3), 337-344, 2017 | 100 | 2017 |
| Nanotechnology based therapeutics for lung disease M Doroudian, R MacLoughlin, F Poynton, A Prina-Mello, SC Donnelly Thorax 74 (10), 965-976, 2019 | 98 | 2019 |
| Chemical design of both a glutathione-sensitive dimeric drug guest and a glucose-derived nanocarrier host to achieve enhanced osteosarcoma lung metastatic anticancer selectivity L Su, R Li, S Khan, R Clanton, F Zhang, YN Lin, Y Song, H Wang, J Fan, ... Journal of the American Chemical Society 140 (4), 1438-1446, 2018 | 95 | 2018 |
| Emerging role of exosomes as biomarkers in cancer treatment and diagnosis NA Hanjani, N Esmaelizad, S Zanganeh, AT Gharavi, P Heidarizadeh, ... Critical reviews in oncology/hematology 169, 103565, 2022 | 77 | 2022 |
| Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro KR Paudel, R Wadhwa, XN Tew, NJX Lau, T Madheswaran, ... Life sciences 276, 119436, 2021 | 75 | 2021 |
| Nanotechnology in pulmonary medicine M Doroudian, A O’Neill, R Mac Loughlin, A Prina-Mello, Y Volkov, ... Current opinion in pharmacology 56, 85-92, 2021 | 73 | 2021 |
| Investigation of the quantity of exhaled aerosols released into the environment during nebulisation JA McGrath, A O’Sullivan, G Bennett, C O’Toole, M Joyce, MA Byrne, ... Pharmaceutics 11 (2), 75, 2019 | 69 | 2019 |
| Development of a drug delivery system for efficient alveolar delivery of a neutralizing monoclonal antibody to treat pulmonary intoxication to ricin R Respaud, D Marchand, T Pelat, KM Tchou-Wong, CJ Roy, C Parent, ... Journal of Controlled Release 234, 21-32, 2016 | 67 | 2016 |
| Polysaccharide-based nanomedicines targeting lung cancer AA Bhat, G Gupta, KS Alharbi, O Afzal, ASA Altamimi, WH Almalki, I Kazmi, ... Pharmaceutics 14 (12), 2788, 2022 | 63 | 2022 |
| Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro KR Paudel, M Mehta, GHS Yin, LL Yen, V Malyla, VK Patel, ... Environmental Science and Pollution Research 29 (31), 46830-46847, 2022 | 59 | 2022 |
| Biopolymer-based nanoparticles for cystic fibrosis lung gene therapy studies E Fernández Fernández, B Santos-Carballal, C De Santi, JM Ramsey, ... Materials 11 (1), 122, 2018 | 55 | 2018 |
| Comparison of heterosubtypic protection in ferrets and pigs induced by a single-cycle influenza vaccine B Holzer, SB Morgan, Y Matsuoka, M Edmans, FJ Salguero, H Everett, ... The Journal of Immunology 200 (12), 4068-4077, 2018 | 54 | 2018 |
| Precise targeting of miRNA sites restores CFTR activity in CF bronchial epithelial cells C De Santi, EF Fernández, R Gaul, S Vencken, A Glasgow, IK Oglesby, ... Molecular Therapy 28 (4), 1190-1199, 2020 | 52 | 2020 |
| Optimized aerosol delivery to a mechanically ventilated rodent RJ MacLoughlin, BD Higgins, JG Laffey, T O'Brien Journal of aerosol medicine and pulmonary drug delivery 22 (4), 323-332, 2009 | 49 | 2009 |
| Investigation of fugitive aerosols released into the environment during high-flow therapy JA McGrath, C O’Toole, G Bennett, M Joyce, MA Byrne, R MacLoughlin Pharmaceutics 11 (6), 254, 2019 | 48 | 2019 |
| Modified Vaccinia Virus Ankara Preferentially Targets Antigen Presenting Cells In Vitro, Ex Vivo and In Vivo AF Altenburg, CE van de Sandt, BWS Li, RJ MacLoughlin, RAM Fouchier, ... Scientific reports 7 (1), 8580, 2017 | 48 | 2017 |
Kamal DuaAssociate ProfessorVerified email at uts.edu.au
